Home | About | Agenda | Speakers | Location | CE Credits | Supporters |
Psychiatric Pharmacotherapy Update Registration
The University of Texas College of Pharmacy welcomes you to the 2014 Psychiatric Pharmacotherapy Update CE event, taking place at the DoubleTree by Hilton in Austin, Texas on October 23-24. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.
Hotel Reservations: See Location website for more information: http://www.utexas.edu/pharmacy/ce/conferences/psych/location.html
Date: Oct 23, 2014 07:00 AM - Oct 24, 2014 05:30 PM
Fee
CE Hours
CE Units
Registration closes on Oct 27, 2014 11:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
|
|
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
|
Requirements for CE Credit
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit. In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, return their completed Record of Attendance Form at the conclusion of the program, and return to this website to complete the online evaluation. |
Registration closes on Oct 27, 2014
at 11:00 PM
Registration Closed
Objectives
- Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
- List key trends in new drug development.
Speaker(s)/Author(s)
Stephen R. Saklad, PharmD, BCPP, Pharm.D., BCPP
|
Activity Number
0067-0000-14-040-L01-PCE Hours
Registration Closed
Objectives
- Describe current trends for treatment of non-combative PTSD.
- Examine the differences between combative and non-combative treatment regiments for PTSD.
Speaker(s)/Author(s)
Alan Peterson, PHARM.D., PHD, ABPP
|
Activity Number
0067-0000-14-041-L01-PCE Hours
Registration Closed
Objectives
- Describe potential functional gains demonstrated by atypical antipsychotics.
- Cite evidence supporting the cognitive benefits of antipsychotics.
- Describe data summarizing current trends in treatment for schizophrenia.
- Describe current data in relation to the use of clozapine.
- Explain alternative treatments of schizophrenia.
- Describe cognitive therapy approaches in relation to pharmacotherapy treatments.
Speaker(s)/Author(s)
Karen Rascati, Ph.D.
|
|
Troy Moore PharmD, MS Pharm, BCPP
|
Activity Number
0067-0000-14-042-L01-PCE Hours
Registration Closed
Objectives
- Describe the effect of genetics on psychotropic disposition and response.
- Identify cultural factors that influence medication use.
- Discuss the scope of cultural and diversity competency.
Speaker(s)/Author(s)
Y.W. Francis Lam, Pharm.D., FCCP
|
Activity Number
0067-0000-14-043-L01-PCE Hours
Registration Closed
Objectives
- Describe data/trends in surge of autism diagnosis in TX/US.
- Discuss pharmacotherapy treatments
- Discuss the scope of cultural and diversity competency.
Speaker(s)/Author(s)
Dilip J Karnik, M.D.
Brief Bio : Dr. Karnik site at Dell Children's Hospital http://www.speciallyforchildren.com/specialties/neurology/index.asp |
Activity Number
0067-0000-14-044-L01-PCE Hours
Registration Closed
Speaker(s)/Author(s)
M. Lynn Crismon, Pharm.D., FCCP, BCCP
|
Activity Number
0067-0000-14-045-L01-PCE Hours
Registration Closed
Activity Number
0067-0000-14-046-L01-PCE Hours
Registration closes on Oct 27, 2014
at 11:00 PM
Registration Closed
Activity Number
0067-0000-14-047-L01-PCE Hours
Registration Closed
Activity Number
0067-0000-14-048-L01-PCE Hours
Registration Closed
Objectives
- Describe the trends of patients moving from prescription drug muses to illegal substance / heroin use.
- Discuss treatment options for heroin addiction.
- Discuss ethical dilemmas practitioners face when a patient stops use of prescription pills for illegal substances
Speaker(s)/Author(s)
Jane Maxwell, Ph.D.
|
Activity Number
0067-0000-14-049-L01-PCE Hours
Registration Closed
Objectives
- Describe trends resulting in additions to prescription drugs. Discuss methods to avoid addiction. Discuss treatment methods to end addiction.
Speaker(s)/Author(s)
Thomas Kosten |
Activity Number
0067-0000-14-050-L01-PCE Hours
Registration Closed
Speaker(s)/Author(s)
Dr. Igor Grant |
|
Jane Maxwell, Ph.D.
|
|
Thomas Kosten |
Activity Number
0067-0000-14-051-L01-PCE Hours
Registration Closed
Objectives
- Describe a patient-centered, team approach to mental health care in primary care.
- Design an evidence-based medication regimen that fits the individual patient's needs.
- Evaluate the medication regimen to ensure that it is appropriate, effective, safe, and conveninet.
Speaker(s)/Author(s)
Carla Cobb, Pharm.D., BCPP
|
Activity Number
0067-0000-14-052-L01-PCE Hours
Registration Closed
Objectives
- Describe recent changes and trends in the treatment of dementia
- Describe side effects, Black Box Warnings, and other risks associated with antipsychotic therapy.
- Discuss alternatives to antipsychotic therapy.
- Antidepressants in bipolar depression or Ketamine in Depression
Speaker(s)/Author(s)
Rajesh Tampi, MD, MS, DFAPA, MD, MS, FAPA
|